Track the 대성미생물 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 대성미생물 has logged 19 reports. Market capitalisation: €24.6bn. The latest transaction was disclosed on 4 June 2026 (Purchase). Among the most active insiders: 최승훈. The full history is free.
19
Insider Decl.
n/a
Thresholds
€17m
15 ops.
Buy Volume
€7m
1 ops.
Sell Volume
33Σ signal
Buys €17m€7m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,798 of 28,169 companies
40.9
score / 100
Value
52
Quality
30
FCF yld4.4%
Earn yld2.5%
EV/EBITDA12.5x
ROE1.9%
Gross mgn25%
Net mgn2.3%
Debt/EBITDA5.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
대성미생물 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development and production of microbiological products.